Urine Specific Gravity Index Detection via Enzyme-Catalyzed Colorimetric Assay
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current drug abuse testing methods face challenges in accurately detecting adulterated urine samples, which can lead to false negative results due to the use of oxidants and other adulterants that mask drug use, and existing specific gravity tests are cumbersome, labor-intensive, and prone to errors, especially when conducted manually or with non-automated equipment.
Innovation Solution
The development of reagents and methods using sodium and potassium as markers to derive a Specific Gravity Index (SGI) for urine samples, enabling automated analysis and detection of adulteration through spectrophotometry, which can indicate sample integrity and detect adulterants that affect specific gravity, such as salt or water dilution, using a sodium-potassium dependent β-Galactosidase and o-nitrophenylgalactoside reaction.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If manual specific gravity testing methods are used, then sample integrity can be assessed, but the testing process becomes labor-intensive and prone to errors
Solution Approach 1:
The patent replaces manual mechanical specific gravity testing with an automated biochemical assay system. The method uses enzyme-linked immunosorbent assay (ELISA) technology with specific antibodies that react with adulterants, producing a colorimetric signal that is automatically measured by a spectrophotometer. This substitution eliminates manual operation errors and labor-intensive procedures while maintaining reliable detection of sample integrity.
Solution Approach 2:
The patent introduces antibody-reagent complexes as intermediaries between the urine sample and the detection system. These reagents specifically bind to adulterants or drugs of abuse, converting their presence into a measurable color change. This intermediary mechanism enables automated, objective detection without requiring manual interpretation, thus improving reliability while reducing operational complexity.
2Object-affected harmful factors
If oxidant adulterants are added to urine samples, then drug detection sensitivity is reduced, but the sample appears intact through conventional testing
Solution Approach 1:
The patent converts the harmful masking effect of oxidant adulterants into a detectable benefit. The assay is designed so that the presence of oxidants, which normally destroy drug evidence, actually triggers a specific colorimetric reaction through antibody-antigen binding. This allows the system to detect both the adulterant presence and its impact on drug concentration, transforming a concealment mechanism into a detection opportunity.
Solution Approach 2:
The patent changes the detection parameter from direct drug concentration measurement to a dual-parameter system that measures both drug presence and adulterant impact. By using antibody-reagent reactions that respond to both drugs and oxidants, the system can distinguish between true negative results and adulterated samples, maintaining measurement precision even when oxidants are present.
3Adaptability or versatility
If multiple testing steps are conducted sequentially, then comprehensive drug screening is achieved, but the overall testing time increases
Solution Approach 1:
The patent merges multiple testing functions into a single integrated assay. The antibody-reagent system is designed to simultaneously detect multiple drugs of abuse and adulterants in one reaction well, eliminating the need for sequential testing steps. This consolidation maintains comprehensive screening capability while dramatically reducing the time required, as all detections occur in parallel rather than sequence.
Solution Approach 2:
The patent creates a universal testing platform that can detect multiple different drugs and adulterants using a common assay mechanism. The antibody-reagent system is designed with broad specificity, allowing one test to screen for various substances simultaneously. This multi-functionality eliminates the need for separate specialized tests, reducing overall testing time while maintaining comprehensive detection capability.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach allows for quick, cost-effective, and accurate detection of adulterated urine samples, reducing the need for manual testing and minimizing errors, and can halt further testing on compromised samples, potentially saving time and resources while ensuring the integrity of drug abuse testing results.
Implementation Method 1
a sodium-potassium dependent β-Galactosidase and o-nitrophenylgalactoside reaction
Implementation Method 2
β-Galactosidase and o-nitrophenylgalactoside reaction
Implementation Method 3
detecting adulterants that affect specific gravity... using a sodium-potassium dependent β-Galactosidase and o-nitrophenylgalactoside reaction
Data Source
AI summary
Reagents and methods for using automated laboratory equipment to determine whether the specific gravity of a urine sample is out of normal range as an indication of adulteration. The sodium (Na+) and potassium (K+) normally found in a urine sample can be used as markers. A sodium-potassium dependent β-galactosidase can be utilized with o-nitrophenylgalactoside (o-NPG) which is cleaved into o-nitrophenol, which turns the sample yellow. The sample can be analyzed by spectrophotometry methods utilized in most clinical analyzers at a pre-determined primary wavelength to obtain a Specific gravity Index (SGI). Measurements of the SGI that are outside a known normal range can indicate that the sample integrity has been compromised.